OXY

Oxytocin

Research Healing FDA-approved

A hormone popularly called the 'bonding hormone' (a popular label, not a mechanism). Approved medically as an injectable for labour induction/augmentation and postpartum haemorrhage; intranasal oxytocin has been studied for effects on social behaviour and anxiety, with inconsistent results across trials.

Regulatory status (as of Sept 2026)

Injectable oxytocin is an approved prescription drug for obstetric indications. Intranasal oxytocin for behavioural or psychiatric use is not FDA-approved; the discontinued US nasal spray is not available. Not a 503A compounding-list item addressed by the April 2026 removals or the July 2026 PCAC votes.

See the FDA peptide regulatory tracker · Read our July 27, 2026 dispatch on the FDA PCAC peptide vote
Educational summary. Every effect described below is drawn from the cited published research and describes what was observed in research subjects — not a promise of results, a dose recommendation, or an endorsement for human use. Many peptides are not FDA-approved. Consult a licensed healthcare provider before making any health decision. Full disclaimer.

3 studies referenced · Last reviewed Oct 1, 2026 · Reviewed by The Peptide Dispatch Editorial Team · How we research & label content

TL;DR — Oxytocin at a Glance

Oxytocin is an FDA-approved prescription drug. A hormone popularly called the 'bonding hormone' (a popular label, not a mechanism).

Half-life3-5 minutes (but effects longer)
How it's given in studiesIntranasal
Research stageFDA-approved
Dosing
Published research: Intranasal oxytocin bioavailability is about 2% in rats, with brain delivery occurring largely by direct…
detailsIntranasal oxytocin bioavailability is ~2% in rats, with brain delivery occurring largely by direct nose-to-brain transport; a human phase 1 study of a related intranasal oxytocin-receptor agonist used 5-400 microgram doses.
Community-reportedCommunity-reported: 10–40 IU intranasal, intranasal

Published-research dosing is what was given in the cited studies (species and units as reported). Community-reported dosing is what users describe, not from clinical studies. Neither is a recommendation. Not medical advice.

Where each point comes from: Clinicalhuman trials and FDA labels   Lab / animalrodent, cell and ex vivo studies   Community-reporteduser experience and commonly used protocols, not from clinical studies

How It Works

In plain terms: It is a natural hormone that acts on the uterus and the brain; its approved uses are in childbirth. Activates oxytocin receptors in the brain and periphery. Its approved uses act on the uterus (labour induction or augmentation, postpartum haemorrhage). Central effects on social behaviour are proposed; intranasal delivery to the brain was studied in rats (Tanaka 2018), and human trial results are inconsistent.

Effects Reported in Research

How to read this: Each item below is an effect observed in research subjects in the cited studies — think of Dexter, our stand-in research subject. These are findings from the literature, not results you should expect, and not medical advice.

  • ClinicalIntranasal oxytocin has been studied for effects on social behaviour and anxiety, with inconsistent results across trials (investigational, off-label)
  • ClinicalApproved use (injectable): labour induction/augmentation and postpartum haemorrhage

What Users Report (Community, Not Clinical)

Commonly reported protocol

Community-reportedIn user communities, Oxytocin is typically run at 10–40 IU (intranasal). This is not a recommendation.

Side effects users report

  • Community-reportedEmotional effects

Side effects reported in studies are listed separately below.

Community reports are anecdotal, vary widely in product quality and purity, and are not medical advice. Talk to a licensed provider.

Side Effects and Safety Notes

  • ClinicalHeadache was the most common adverse event in the intranasal oxytocin-agonist phase 1 study, all mild
  • Nasal irritation with intranasal administration
  • IV obstetric use carries distinct risks (uterine hyperstimulation, water intoxication with prolonged infusion)

References

  1. Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application
    Tanaka A, Furubayashi T, Arai M, Inoue D, Kimura S, Kiriyama A et al. Molecular pharmaceutics. 2018. PMID: 29338251.
    Study type: Rat PK and brain-distribution study, IV and intranasal.
    DOI: 10.1021/acs.molpharmaceut.7b00991 · PubMed
  2. Short communication: pharmacokinetics of oxytocin administered intranasally to beef cattle
    Wagner BK, Relling AE, Kieffer JD, Moraes LE, Parker AJ. Domestic animal endocrinology. 2020. PMID: 31830691.
    Study type: Latin-square PK study in 5 steers, intranasal.
    DOI: 10.1016/j.domaniend.2019.106387 · PubMed
  3. First-in-Human Study of Merotocin, a Short-Acting Peptidic Oxytocin Receptor Agonist for Lactation Support
    Bagger Y, Holmqvist C, Jonker DM, Klein BM, Urban LE. Clinical pharmacology in drug development. 2025. PMID: 40781993.
    Study type: Phase 1 randomized placebo-controlled, intranasal and IV, healthy women.
    DOI: 10.1002/cpdd.1581 · PubMed

Get the weekly Dispatch

New research, FDA peptide updates, and what users are reporting. One email a week. Unsubscribe anytime.

How Oxytocin Compares

PeptideHalf-LifeRouteResearch Status
Oxytocin3-5 minutes (but effects longer)IntranasalFDA-approved
CerebrolysinNo published PK data foundIV or IM injectionApproved outside US
CortexinNo published PK data foundIntramuscular injectionApproved outside US
Thymulin (Zn-FTS)UnknownSubcutaneous injectionPreclinical (animal)
VIP (Vasoactive Intestinal Peptide)~2 minutesIntranasal or subcutaneousPhase 3

Values reflect figures reported in published research. Compare any peptides side-by-side →

Frequently Asked Questions

What is Oxytocin?
A hormone popularly called the 'bonding hormone' (a popular label, not a mechanism). Approved medically as an injectable for labour induction/augmentation and postpartum haemorrhage; intranasal oxytocin has been studied for effects on social behaviour and anxiety, with inconsistent results across trials.
How does Oxytocin work?
In plain terms: It is a natural hormone that acts on the uterus and the brain; its approved uses are in childbirth. Activates oxytocin receptors in the brain and periphery. Its approved uses act on the uterus (labour induction or augmentation, postpartum haemorrhage). Central effects on social behaviour are proposed; intranasal delivery to the brain was studied in rats (Tanaka 2018), and human trial results are inconsistent.
What is the research status of Oxytocin?
Oxytocin is at the following stage in the published literature: FDA-approved. All information is for research and educational purposes only.
What is the half-life of Oxytocin?
Reported half-life: 3-5 minutes (but effects longer).
How is Oxytocin administered in research?
Reported administration route in the literature: Intranasal. This is not a recommendation for human use.

Quick Actions

Category

This peptide belongs to the Research category. View All Research Peptides

Related Categories

Healing

Related Peptides

  • Cerebrolysin (CERE, Research) — View Profile
  • Cortexin (CORT, Research) — View Profile
  • KPV (KPV, Immune) — View Profile
  • LL-37 (LL37, Immune) — View Profile

From Our Affiliated Clinic

Prefer physician oversight? See how 1836 Wellness works.

1836 Wellness is a physician-supervised clinic in Houston, TX. Discussing a compound on this page is not an offer to prescribe or supply it.

See how it works →

Disclosure: The Peptide Dispatch and 1836 Wellness are commonly owned by 1836 Wellness LLC. We may benefit financially if you become a client of 1836 Wellness. Learn more.

Sources & Methodology

Dosing, half-life figures, and mechanism descriptions on this page are compiled from peer-reviewed published research, with the species and study type stated where reported. Figures labeled “Dosing used in published research” describe what was given in those studies and do not constitute dosing recommendations for any human use. Each cited paper is listed with DOI and PubMed links in the References section above. Found an error? Contact us.

← Back to Peptide Library Dosing Calculator The Dispatch Home